QP biotechnology issues

1 Day/s

CPD Hours: 7

Online, in-house

This course will provide participants with a good overview of the quality and regulatory issues surrounding the development and production of biopharmaceuticals for global use.

The QP needs to understand the quality issues associated with the manufacture of biopharmaceuticals. Other modules in the RSSL QP Training Programme are based around the Study Guide, and therefore cover biotechnology products alongside other product types.

This workshop has been designed to pull together the information in a way that provides participants with a good overview of the quality and regulatory issues surrounding the development and production of biopharmaceuticals for global use.

This course has value for a wide audience, as it provides a good introduction to this exciting sector. It will give a foundation level knowledge that will help potential contract QPs, those moving in to the biotechnology sector and all those who may need an understanding for auditing purposes.
This course includes the following topics/sessions:

  • What is Biotech all about?
  • Process Overview
  • Facilities, Utilities and Equipment
  • Controlling Contamination
  • Quality Systems
  • Sampling and Testing
  • Batch Release
  • Scenarios / Group Work and Plenary Discussion
  • What does the Future Hold?

    By the end of the course you will:

    • Know how biopharmaceuticals are different from other products
    • Know what the key regulations are and the impact they have
    • Understand the biopharmaceutical process and the development of products
    • Understand the facilities, utilities and equipment and how they are qualified
    • Know what the contamination risks are and the controls to minimise the risks, including viral and TSE control strategies
    • Understand quality systems for biopharmaceuticals
    • Have an insight in to the types of testing regimes and their issues, during both development and licensed product manufacture
    • Understand the batch sequencing process, the types of problems encountered during manufacture and testing, and how they can be resolved
    • Understand the future of biopharmaceuticals
Book your place
Select Date & Location

ex VAT

Bring this course in-house

Special offer

Helping your training budget go further

We offer a number of discounts and specials offers on our training courses including Group booking, NHS and Seasonal discounts.

Meet the tutors

Suzanne Aldington

Suzanne is a biotechnology professional with over 30 years’ experience in academia and in the biotechnology industry. She spent 20 years at Lonza Biologics in Slough, during this time, she held several positions including purification process development, scale up and technology transfer to GMP manufacturing facilities within the Lonza network. Suzanne is Director of Cell and Gene Therapy Technology at Orchard Therapeutics, a CGT company which focuses on treatments for rare genetic diseases.

Related Course

Gettyimages 723513929Flip

Introduction to ATMPs and route to market

This course discusses the key regulatory requirements and issues surrounding developing and translating an advanced therapeutic medicinal product (ATMP) to the clinical trial and market authorisation application.